Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pregnancy and thyroid disorders].

G Ducarme1, J Bertherat, E Vuillard

  • 1Service de gynécologie obstétrique, hôpital Beaujon, APHP, université Paris-VII, 100, boulevard du Général-Leclerc, 92110 Clichy, France.

La Revue De Medecine Interne
|April 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

sFlt-1/PlGF ratio use does not reduce hospitalisation duration in suspected preeclampsia: the PRECOG study, a multicentre randomised trial.

Scientific reports·2025
Same author

Prenatal diagnosis of a patent urachus in a monochorionic twin pregnancy: Follow-up and outcome.

European journal of obstetrics, gynecology, and reproductive biology·2025
Same author

Reply: Evaluation of methodological and analytical approaches in assessing intra-individual serum progesterone variability on frozen embryo transfer day across hormone replacement therapy cycles.

Human reproduction (Oxford, England)·2025
Same author

Reference values for biochemical tests during pregnancy: Analysis of the PRECAREbio Cohort and correlation with precarious status.

Journal of gynecology obstetrics and human reproduction·2024
Same author

Progesterone levels do not differ between patients with or without endometriosis/adenomyosis both in those who conceive after hormone replacement therapy-frozen embryo transfer cycles and those who do not.

Human reproduction (Oxford, England)·2024
Same author

Intra-individual variability of serum progesterone levels on the day of frozen blastocyst transfer in hormonal replacement therapy cycles.

Human reproduction (Oxford, England)·2024
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Pregnancy and thyroid disorders are common. Monitoring maternal hyperthyroidism and hypothyroidism ensures healthy newborns, but iodine deficiency remains a concern for neurodevelopment.

Area of Science:

  • Endocrinology
  • Obstetrics
  • Perinatology

Context:

  • Thyroid disorders frequently occur during pregnancy, impacting both maternal and fetal health.
  • Management strategies differ significantly between maternal hyperthyroidism and hypothyroidism.
  • Iodine deficiency poses a risk to neurodevelopmental outcomes, particularly in regions like France.

Purpose:

  • To outline the management of maternal thyroid disorders during pregnancy.
  • To emphasize the importance of fetal and biological monitoring.
  • To highlight the ongoing challenges of iodine deficiency and the benefits of multidisciplinary care.

Summary:

  • Maternal hyperthyroidism requires strict fetal thyroid monitoring via echographic scanning to ensure a healthy euthyroid newborn.

Related Experiment Videos

  • Maternal hypothyroidism, with adequate substitution and biological monitoring, generally has no significant impact on pregnancy.
  • Addressing iodine deficiency is crucial for optimal neurodevelopmental outcomes, though it remains an unresolved issue in some areas.

    • Impact:

    • Effective management of maternal thyroid disorders promotes healthy pregnancy outcomes and euthyroid newborns.
    • Standardized monitoring protocols are essential for optimizing care during pregnancy.
    • Further research and public health initiatives are needed to address iodine deficiency and its long-term effects on child development.